Publicaciones en las que colabora con Rosa María Tolon Rafael (5)

2012

  1. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors

    British Journal of Pharmacology, Vol. 166, Núm. 4, pp. 1474-1489

2011

  1. Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: An intravital microscopy study

    Journal of Neuroinflammation, Vol. 8

2010

  1. The endocannabinoid system and amyloid-related diseases

    Experimental Neurology, Vol. 224, Núm. 1, pp. 66-73

2009

  1. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages

    Brain Research, Vol. 1283, pp. 148-154

2007

  1. The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats

    Pediatric Research, Vol. 62, Núm. 3, pp. 255-260